Bright Minds Biosciences to Present at Jefferies Healthcare Conference
Ticker: DRUG · Form: 6-K · Filed: May 28, 2025 · CIK: 1827401
Sentiment: neutral
Topics: conference-presentation, news-release
TL;DR
Bright Minds Biosciences presenting at Jefferies Healthcare Conference May 28th.
AI Summary
Bright Minds Biosciences Inc. announced on May 28, 2025, that it will present at the 2025 Jefferies Global Healthcare Conference. The company, located at 19 Vestry Street, New York, NY 10013, will be represented by its Chief Financial Officer, Ryan Cheung.
Why It Matters
Presenting at a major healthcare conference provides visibility and potential investor interest for Bright Minds Biosciences' pipeline and strategic initiatives.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a presentation at a conference and does not contain significant financial or operational news.
Key Players & Entities
- Bright Minds Biosciences Inc. (company) — Registrant
- Ryan Cheung (person) — Chief Financial Officer
- May 28, 2025 (date) — Filing Date and Presentation Announcement
- 2025 Jefferies Global Healthcare Conference (event) — Conference where the company will present
- 19 Vestry Street, New York, NY 10013 (location) — Company's principal executive office
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is filed to report a news release dated May 28, 2025, announcing that Bright Minds Biosciences Inc. will present at the 2025 Jefferies Global Healthcare Conference.
Who is representing Bright Minds Biosciences Inc. at the conference?
Ryan Cheung, the Chief Financial Officer of Bright Minds Biosciences Inc., is signing the report, indicating his likely involvement in the conference presentation.
When was the news release submitted?
The news release was submitted as part of the Form 6-K filing on May 28, 2025.
What is the company's primary business?
Bright Minds Biosciences Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
Where is Bright Minds Biosciences Inc. headquartered?
The company's principal executive office is located at 19 Vestry Street, New York, NY 10013.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 28, 2025 by Ryan Cheung regarding BRIGHT MINDS BIOSCIENCES INC. (DRUG).